4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: July 18, 2012
Period of Report: July 16, 2012
Accession Number: 0001144204-12-040005

View Document ↗ View on SEC.gov ↗